Synthesized molecules studied as weapon to stop cell division in cancer cells

Blacksburg, Va., Aug. 23, 2004 -- An enzyme called Pin1, a gatekeeper of cell division, is present at high levels in a wide variety of cancer cells. Virginia Tech researchers who are designing small molecules to inhibit Pin1 are seeing promising results with a small U-shaped molecule.

Felicia Etzkorn, associate professor of chemistry, will report on her group's achievements in presentations at the 228th American Chemical Society (ACS) National Meeting in Philadelphia August 22-26.

Pin1 regulates the protein Cdc25, which initiates mitosis or cell division. Without Pin1, the cell enters programmed cell death -- which is good if it's a cancer cell.

"It makes sense to inhibit the Pin1 enzyme," said Etzkorn.

Protein shape determines biological function. Pin1 works by changing a peptide bond within Cdc25 from the trans shape (a flattened-Z shape) to the cis U-shape and back. This a simple change -- the swing of an arm one way or another to open or close the U results in a large conformation change in a protein.

The researchers synthesized cis and trans shaped inhibitors and introduced them into cancer cells. These inhibitors mimic part of the Cdc25 protein but do not bend to the will of Pin1. The research team discovered that cis inhibits the Pin1 enzyme's function 23 times better than trans. "This is very exciting because it tells us something fundamental about the mechanism.

The Etzkorn group tested the inhibitors in an ovarian cancer cell line. "That was the cell line that was available, but it should work for many cancers," Etzkorn said. "It would probably be particularly effective against breast cancer and prostate cancer. It seems to relate to secondary sexual characteristics."

However, a lot of work remains to be done to develop a drug, she cautions. "For instance, the inhibitor does not cross cell membranes. We can overcome that in the laboratory in order to study effectiveness, but have no

Contact: Susan Trulove
Virginia Tech

Page: 1 2 3

Related biology news :

1. Human Metabolite Of Taxol Synthesized In The Laboratory
2. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
3. Scientists reinvent DNA as template to produce organic molecules
4. Sweet success in targeting sugar molecules to cells in living animals
5. UC Riverside researcher takes snapshots of the movement of molecules in a billionth of a second
6. Scientists pinpoint molecules that generate synapses
7. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
8. Controlling biomolecules with magnetic tweezers
9. Water molecules clump more loosely than previously thought
10. Creating polymers that act like biomolecules
11. A new way to see DNA (and other tiny molecules)

Post Your Comments:

(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead ... near term focus on Type 2 diabetes and associated comorbidities. , Justin brings ... areas and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... Today CJ ... Advantage, which will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient ... The Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) ...
(Date:7/1/2020)... ... 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit ... aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John ... the organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 2020 , ... Bode Technology, a leading provider ... through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical testing ... provides a turnkey solution that includes a comprehensive collection and virus-management program for ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
(Date:7/1/2020)... Colo. (PRWEB) , ... June ... ... of expert tissue data insights, today announced that the launch of a ... results along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... solutions providers, today announced its strong opposition to the recently introduced bicameral ... a blanket ban on most federal use of nearly all biometric and related ...
Breaking Biology Technology:
Cached News: